Late-onset sporadic nemaline myopathy: of the importance of α-actinin immunostaining and of the efficacy of corticosteroids combined with an immunosuppressant

A Chinese retrospective study of 17 individuals with sporadic late-onset nemaline myopathy (SLONM), including four with monoclonal gammopathy of undetermined significance (MGUS), shows positive muscle biopsy immunostaining for anti-α-actinin antibodies in all cases.

  • The first signs appeared at a median age of 54 years.
  • Most had asymmetric proximal limb muscle involvement (71%) and neck extensors (53%) with head droop at first evaluation (41%).
  • Muscle MRI showed preferential involvement of the paravertebral, gluteus minimus and medius, semimembranosus and soleus muscles.
  • Twelve patients (71%) had a follow-up of 5 months to 8 years :

. three of the four patients with MGUS received autologous stem cell transplantation resulting in moderate muscle improvement and complete hematologic remission ;

. the fourth patient was treated with prednisone for 16 months with moderate improvement and a relapse several months after stopping the corticosteroids ;

. one patient with unknown hematological status was treated with low doses of prednisone and died eight years later ;

. six patients without MGUS received corticosteroids combined with immunosuppressive therapy, preceded for three of them by one to three courses of IV immunoglobulin: three had complete remission, while the other three had moderate improvement.

 

Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy: Practical Importance of Anti-α-Actinin Immunostaining. Zhao B, Dai T, Zhao D, Ma X, Zhao C, Li L, Sun Y, Zhang Y, Yan Y, Lu JQ, Liu F, Yan C. Neurol Neuroimmunol Neuroinflamm. 2022 May 17;9(4):e1184.